Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function-Reference-Cited by-同舟云学术

Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function

Published:2015-03-18 Issue:8 Volume:60 Page:2529-2537
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Siddiqui Mohammad S.,Cheang Kai L.,Luketic Velimir A.,Boyett Sherry,Idowu Michael O.,Patidar Kavish,Puri Puneet,Matherly Scott,Stravitz Richard T.,Sterling Richard K.,Sanyal Arun J.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-015-3627-7.pdf

Reference34 articles.

1. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395.

2. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3–16.

3. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121.

4. Söderberg C, Stål P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2009;51(2):595–602.

5. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35:367–372.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes;Digestive Diseases and Sciences;2024-07-10

2. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations;American Journal of Physiology-Endocrinology and Metabolism;2024-05-01

3. Burden of Portal Hypertension Complications is Greater in Patients with Decompensated Cirrhosis and Type 2 Diabetes Short title: Impact of Diabetes on Outcomes In Cirrhosis;2024-03-29

4. Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis;Digestive Diseases and Sciences;2024-03-04

5. Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation;Hepatology;2023-12-13